Together with PD1 blockade, IL-12-mediated recruitment of trNK cells enhances cross-presentation of antigen to CD8 T via cDC1, suggesting this represents a substantial barrier for T-cell focused therapy and that improving the NK/DC/T-cell crosstalk can promote anti-tumor immunity and tumor control. This evidence concerns the gene PDCD1 and neoplasm.